NEW DELHI, Sept. 5 -- India's drug safety authority has raised fresh concerns over two commonly prescribed medicines, warning doctors and patients to watch for potentially serious side effects.

The Indian Pharmacopoeia Commission (IPC), an autonomous body under the Ministry of Health & Family Welfare, has issued safety alerts on Tranexamic Acid and Metoclopramide, according to the IPC's drug safety alert report seen by Mint.

The move follows an analysis of adverse drug reactions (ADRs) collected under the Pharmacovigilance Programme of India (PvPI), the country's national drug safety monitoring system, during August.

Tranexamic Acid-prescribed to control excessive bleeding in conditions such as menorrhagia, nosebleeds, and post-surgery...